Effects of Compound Shenhua Tablet (复方肾华片) on renal tubular Na+-K+-ATPase in rats with acute ischemic reperfusion injury-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of Compound Shenhua Tablet (复方肾华片) on renal tubular Na+-K+-ATPase in rats with acute ischemic reperfusion injury

Published:2014-01-24 Issue:3 Volume:20 Page:200-208
ISSN:1672-0415
Container-title:Chinese Journal of Integrative Medicine
language:en
Short-container-title:Chin. J. Integr. Med.

Author:

Yang Yue,Wei Ri-bao,Zheng Xiao-yong,Qiu Qiang,Cui Shao-yuan,Yin Zhong,Shi Suo-zhu,Chen Xiang-mei

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Complementary and alternative medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11655-014-1740-7.pdf

Reference24 articles.

1. Legrand M, Mik EG, Johannes T, Payen D, Ince C. Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med 2008;14:502–516.

2. Kimura T, Han WS, Pagel P, Nairn AC, Caplan MJ. Protein phosphatase 2A interacts with the Na+,K+-ATPase and modulates its trafficking by inhibition of its association with arrestin. PLoS One 2011;6:e29269.

3. Hu F, Koon CM, Chan JY, Lau KM, Fung KP. The cardioprotective effect of Danshen and Gegen Decoction on rat hearts and cardiomyocytes with post-ischemia reperfusion injury. BMC Complement Altern Med 2012;12:249.

4. Inserte J, Garcia-Dorado D, Hernando V, Barba I, Soler-Soler J. Ischemic preconditioning prevents calpainmediated impairment of Na+/K+-ATPase activity during early reperfusion. Cardiovasc Res 2006;70:364–373.

5. Graebe M, Brond L, Christensen S, Nielsen S, Olsen NV, Jonassen TEN. Chronic nitric oxide synthase inhibition exacerbates renal dysfunction in cirrhotic rats. Am J Physiol Renal Physiol 2004;286:F288–F297.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The therapeutic effect of Shenhua tablet against mesangial cell proliferation and renal inflammation in mesangial proliferative glomerulonephritis;Biomedicine & Pharmacotherapy;2023-09

2. Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney;Frontiers in Pharmacology;2023-04-05

3. Renal-Protective Effects and Potential Mechanisms of Traditional Chinese Medicine after Ischemia-Reperfusion Injury;Evidence-Based Complementary and Alternative Medicine;2021-02-19

4. Protective Effects and Mechanisms of Shenhua Tablet (肾华片) on Toll-Like Receptors in Rat Model of Renal Ischemia-Reperfusion Injury;Chinese Journal of Integrative Medicine;2017-05-03

5. Protective effects of astragaloside in rats with adriamycin nephropathy and underlying mechanism;Chinese Journal of Natural Medicines;2016-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3